This document summarizes a presentation on future compliance requirements related to medical devices. It discusses changes coming in how medical devices are named (GMDN), tracked (UDI), and have data captured (AIDC/GS1 coding). The Global Medical Device Nomenclature (GMDN) will standardize device names. Unique Device Identification (UDI) will assign each device a unique identifier tracked in a public database. Automatic identification like GS1 coding will help interface equipment and data. Hospitals should prepare by understanding these changes to integrate new identification standards.
Medical Devices registration in Japan , quality system requirements and evaluation and investigation of medical devices in regulated countries ASEAN, China JAPAN and WHO regulations. quality and ethical considerations regulatory and documentation requirements for marketing medical devices and IVDs in regulated countries.
The slides explain 21 CFR Part 812. It includes all the guidelines to be followed by any manufacturer and investigator while manufacturing and investigating the safety, efficacy of the medical device.
NSF certification, Standard for dietary supplementAtul Bhombe
Manufacturers, regulators and consumers look to NSF International for the development of public health standards and certification programs that help protect the world’s food, water, consumer products and environment. NSF is a global, independent organization, our standards team facilitates development of public health standards, and our service teams test, audit and certify products and services
It contains details rules and regulations /legislation of Pharmaceuticals, Cosmetics, Active Substance Masters File, Investigational Medicinal Product Dossier for European Union
Medical Devices registration in Japan , quality system requirements and evaluation and investigation of medical devices in regulated countries ASEAN, China JAPAN and WHO regulations. quality and ethical considerations regulatory and documentation requirements for marketing medical devices and IVDs in regulated countries.
The slides explain 21 CFR Part 812. It includes all the guidelines to be followed by any manufacturer and investigator while manufacturing and investigating the safety, efficacy of the medical device.
NSF certification, Standard for dietary supplementAtul Bhombe
Manufacturers, regulators and consumers look to NSF International for the development of public health standards and certification programs that help protect the world’s food, water, consumer products and environment. NSF is a global, independent organization, our standards team facilitates development of public health standards, and our service teams test, audit and certify products and services
It contains details rules and regulations /legislation of Pharmaceuticals, Cosmetics, Active Substance Masters File, Investigational Medicinal Product Dossier for European Union
This whitepaper provides an overview of Chinese Medical Device Regulations. This includes an overview of the Chinese medical device market, medical device regulatory authorities, medical device registration procedure and medical device classification. It also provides information on regulations regarding product standard, type testing, and clinical trials. This paper is meant for anyone within the regulatory affairs industry who is looking to learn more about medical device regulations and product registration in China.
For more information, contact us for a free 15 minute consultation at http://www.pacificbridgemedical.com/contact-us/.
Premarket Notification The 510(k) ProcessMichael Swit
June 5, 2012 presentation to the Food & Drug Law Institute Introduction to Medical Device Law Conference, Palo Alto, CA, focusing on:
I.The Legal Framework For 510(k) Determinations
II.510(k) Preparation – From Planning to Content
A. Predicates: researching predicates, combination predicates, and pre-amendment predicates
B. Strategy: choosing the right claim and introducing new features
C. Assessing data requirements/pre-IDE meetings
III. Device Modifications - Choosing The Right Regulatory Mechanism
IV.The FDA Review
V.What To Do When Your Substantial Equivalence Argument Is Rejected
V. Special Topics: User Fees, Combination Products
VI. Lessons Learned: Seeing The 510(k) From The Reviewer’s Perspective
VII. Recent Trends, 510(k) Reform
VIII. Case Study
A guideline on medical devices designed internationally for harmonization.
As the site access is unavailable have managed the data for easy access of the details for the Regulatory affairs aspirants of Masters of Pharmacy
Acceptance of foreign clinical trials.pptxdipakkendre2
FDA guidence for industry acceptance of foreign clinical trials. -
Clinical trials conducted under IND
Clinical trials not conducted under IND
Good clinical practices
Acceptance of foreign clinical studies
Waivers
21CFR 320- BIO AVAILABILITY AND BIO EQUIVALENCE REQUIREMENTSPallavi Christeen
this presentation describes briefly about Bioavailability and Bioequivalence requirements as per US FDA Code of Federal Regulations under title 21 and chapter 320
This whitepaper provides an overview of Chinese Medical Device Regulations. This includes an overview of the Chinese medical device market, medical device regulatory authorities, medical device registration procedure and medical device classification. It also provides information on regulations regarding product standard, type testing, and clinical trials. This paper is meant for anyone within the regulatory affairs industry who is looking to learn more about medical device regulations and product registration in China.
For more information, contact us for a free 15 minute consultation at http://www.pacificbridgemedical.com/contact-us/.
Premarket Notification The 510(k) ProcessMichael Swit
June 5, 2012 presentation to the Food & Drug Law Institute Introduction to Medical Device Law Conference, Palo Alto, CA, focusing on:
I.The Legal Framework For 510(k) Determinations
II.510(k) Preparation – From Planning to Content
A. Predicates: researching predicates, combination predicates, and pre-amendment predicates
B. Strategy: choosing the right claim and introducing new features
C. Assessing data requirements/pre-IDE meetings
III. Device Modifications - Choosing The Right Regulatory Mechanism
IV.The FDA Review
V.What To Do When Your Substantial Equivalence Argument Is Rejected
V. Special Topics: User Fees, Combination Products
VI. Lessons Learned: Seeing The 510(k) From The Reviewer’s Perspective
VII. Recent Trends, 510(k) Reform
VIII. Case Study
A guideline on medical devices designed internationally for harmonization.
As the site access is unavailable have managed the data for easy access of the details for the Regulatory affairs aspirants of Masters of Pharmacy
Acceptance of foreign clinical trials.pptxdipakkendre2
FDA guidence for industry acceptance of foreign clinical trials. -
Clinical trials conducted under IND
Clinical trials not conducted under IND
Good clinical practices
Acceptance of foreign clinical studies
Waivers
21CFR 320- BIO AVAILABILITY AND BIO EQUIVALENCE REQUIREMENTSPallavi Christeen
this presentation describes briefly about Bioavailability and Bioequivalence requirements as per US FDA Code of Federal Regulations under title 21 and chapter 320
Compliance with medical standards iec 62304, iso 14971, iec 60601, fda title ...Intland Software GmbH
Check out our latest webinar to learn more about complying with IEC 62304, ISO 14971, IEC 60601, and relevant FDA regulations (for instance, Title 21 CFR Part 11 about electronic signatures). In this webinar, we discussed the requirements set forth by these standards. We also showed our Intland's Medical IEC 62304 Template to leverage codeBeamer ALM's advanced capabilities and to facilitate compliance with these regulations.
Esperanto for Engineers, Technical Talk for Medical EngineersPaul Blackett
Presentation given at the 2012 NPAG Conference in Rugby UK. Some suggestions as to how we can better develop our 'technical talk' and what has already been developed and available.
Join this webinar to learn:
• What SPL is
• How it affects medical devices
• The relationship between SPL and UDI
• What medical device manufacturers can learn from the pharmaceutical industry
• How you can automatically create SPL documents with your standard labeling content
Máy được trang bị sẵn hệ điều hành Windows 10 Home.
Sản phẩm có đầy đủ các cổng kết nối phục vụ nhiều mục đích.
Máy tính xách tay được trang bị hệ thống bảo mật vân tay.
Thiết kế của máy vô cùng sang trọng, thanh lịch và nhẹ nhàng.
Màn hình có chất lượng hình ảnh ổn định, chống lóa mắt tốt.
Nguồn: https://laptops.vn/san-pham/dell-vostro-5468/
Understanding compulsory registration scheme of bisLabgo
CRS (Compulsory Registration Scheme) was introduced by Department of Electronics and Information Technology (DeitY – now MeitY) along with Bureau of Indian Standards (BIS) with an aim to safeguard consumer interest for various electronics, telecom and I.T. products.
Visit: http://labgo.in/
Nếu bạn đang là sinh viên, có nhu cầu mua máy tính cá nhân nhưng còn băn khoăn chưa biết nên mua sản phẩm nào thì Dell sẽ là một trong những hãng đáng để bạn tìm hiểu. Trong số rất nhiều dòng máy, Dell Inspiron 5370 đặc biệt sở hữu nhiều ưu điểm nổi bật và phù hợp với đối tượng là sinh viên. Vậy, sản phẩm này có những gì, hãy cùng khám phá ngay bây giờ qua bài viết dưới đây của chúng tôi.
Nguồn: https://laptops.vn/san-pham/dell-inspiron-5370/
FREYR UDI VISION SERIES SESSION 1 - UDI READINESSFreyr Solutions
Very few device manufacturers have experienced the impact and challenges faced during UDI compliance. A very crucial aspect being aware and assessing the level of UDI readiness, implementation of appropriate standards, feasible technologies and ultimately achieving UDI compliance is a major task.
Unique Device Identification or UDI is a forever project. What's the best way for orthopaedic device companies to receive return on their investment? What best practices can be learned for a continually-smooth process? How can the data be leveraged to enhance your company’s value proposition? The true value of UDI is not in the identification number, but in the data that can be generated as a result of UDI. This session will provide attendees with an outline of the opportunities that manufacturers can leverage beyond implementation.
Sản phẩm sở hữu thiết kế đẹp mắt, nổi bật và tinh tế.
Máy mang đến những trải nghiệm âm thanh tốt nhất.
Hiệu năng máy mang đến vô cùng ổn định, load nhanh.
Thời lượng pin cao, có thể sử dụng trong nhiều giờ.
Mua máy được tặng kèm Windows bản quyền.
Nguồn: https://laptops.vn/san-pham/dell-inspiron-7567/
As per FDAs UDI final ruling, GUDID will accept only DI information and it is the responsibility of the medical device manufacturer to maintain the PI information for any future regulatory and quality audits
UDI: What & How within the overall Medical Device value chainnancykathlen
Free Webinar on Unique Device Identification (UDI): What & How within overall Medical Device Value Chain June 18th 2015. This webinar provides insights into various aspects of UDI, discuss the operational aspects of implementing and integrating UDI within the overall Medical Device value chain.
IFPMA-TFDA Workshop on Couterfeit Medicines
‘Integrated Approach Against Fake Medicines’
Session 2: Supply Chain Integrity
On 6th February 2015
At Taipei International Convention Center
Taipei, Taiwan
Implementing Agile in an FDA Regulated EnvironmentTechWell
Developing medical devices that are subject to FDA approval has traditionally followed the waterfall methodology, largely due to the structure of the regulations that govern development practices. But we know from myriad case studies in different industries that agile methodologies are far superior in providing the highest value to customers in the shortest time to market. Neal Herman shares how one developer of complex medical devices embraced agile software development practices and proved that it could not only develop software faster with higher quality but also meet all regulatory requirements. Convincing the internal quality management, systems engineering, and regulatory departments was difficult, but the software department was able to overcome these obstacles and fundamentally change the company’s philosophy on product development. Since 2012, software development productivity is up 100 percent, and quality is up 200 percent. Now, after seeing these gains from the software department, agile is being rolled out to all areas of R&D including hardware.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
1. Paul A Blackett
Medical Engineering Operations Manager
Lancashire Teaching Hospitals NHS
Foundation Trust
Preparing forPreparing for
futurefuture
compliancecompliance
requirementsrequirements
2. Paul A Blackett: SBK Compliance Conference
2013
What’s
Changin
g?
What we
call our
medical
devices!
Where
we get
our data
from...
How
medical
devices
are
tracked
GMDN
AIDC UDI
4. Paul A Blackett: SBK Compliance Conference
2013
C arm
Mobile Image Intensifier
Screening Unit
Mobile x-ray machine
Intensifier, Mobile
5. Paul A Blackett: SBK Compliance Conference
2013
Introducing GMDNIntroducing GMDN
The Global Medical Device NomenclatureThe Global Medical Device Nomenclature
(GMDN) is a system of internationally(GMDN) is a system of internationally
agreed descriptors used to identifyagreed descriptors used to identify
medical device products.medical device products. [1][1]
““
””
6. Paul A Blackett: SBK Compliance Conference
2013
Introducing GMDN
Brings together 6 previous nomenclatures [2]
From ISO 15225:2010 (part of Global
Harmonization)
Used by Manufacturers and EUDAMED
(European Database on Medical Devices)
Maintained by GMDN Agency [1]
Accessible at a low cost to pay for administration
Device type = Preferred Term
8. Paul A Blackett: SBK Compliance Conference
2013
GMDN Data
The device category is the broadest level of the GMDN data. It divides the
entire medical device product market into highest-level groups based on
device application, technology, or other common characteristics. The
standard (ISO 15225) allocates codes for 20 categories. These are:
Category Description
01 Active implantable devices
02 Anaesthetic and respiratory devices
03 Dental devices
04 Electro mechanical medical devices
05 Hospital hardware
06 In vitro diagnostic devices
07 Non-active implantable devices
08 Ophthalmic and optical devices
09 Reusable devices
10 Single use devices
11 Assistive products for persons with disability
12 Diagnostic and therapeutic radiation devices
13 Complementary therapy devices
14 Biological-derived devices
15 Healthcare facility products and adaptations
16 Laboratory equipment
17 Vacant
18 Vacant
19 Vacant
20 Vacant
9. Paul A Blackett: SBK Compliance Conference
2013
GMDN Data
Collective terms are high-level device terms used to aggregate medical
device groups that have common features within the GMDN. Collective terms
may be device names (e.g., Stents, Catheters, Pacemakers) or device
attributes (e.g., Electrophysiology, Absorbable, Home-use); the device name
collective terms are especially used to create hierarchical constructs in the
GMDN.
10. Paul A Blackett: SBK Compliance Conference
2013
GMDN Data
Preferred terms with their unique 5 digit codes are the only terms available for product identification.
The preferred term is the optimal name selected to represent a group of devices (a collection of device
types) that have the same or similar intended use or commonality of technology allowing them to be grouped
in a generic manner, typically without reflecting specialized characteristics such as brand or trade names.
Other Terms exist such as Template, which is used as a root for more specific terms and Synonym which is
used as a navigational toot to find the Preferred Term.
11. Paul A Blackett: SBK Compliance Conference
2013
GMDN Data
Sample data…
12. Paul A Blackett: SBK Compliance Conference
2013
GMDN Data
What it looks like in real life…
•Longer Device Type names!
•Use the Term ID as the Equipment Code?
13. Paul A Blackett: SBK Compliance Conference
2013
GMDN Data
•Integration with SNOMED CT
'Systematized Nomenclature of Medicine Clinical Terms'
The Integration of
GMDNS into Clinical
Terminology and
health records. [3]
14. Paul A Blackett: SBK Compliance Conference
2013
Unique
Device
Identification
15. Paul A Blackett: SBK Compliance Conference
2013
Unique Device Identification [4][5]
A unique code combination that
identifies the attributes of an
individual medical device.
“
”
16. Paul A Blackett: SBK Compliance Conference
2013
Unique Device Identification
• Been around for 20+ years
• GHTF Proposal in 2010
• The FDA progressing in US
• Reusable and single use
• Permanent markings
New guidance due 14 Nov 13
17. Paul A Blackett: SBK Compliance Conference
2013
Unique Device Identification
Made up of 2 parts
The Production Identifier
The Device Identifier
(possible location in use…)
18. Paul A Blackett: SBK Compliance Conference
2013
Unique Device Identification
The Production Identifier
This code specifies the particular production unit.
•Serial Number
•Expiry Date and/or Lot Number
19. Paul A Blackett: SBK Compliance Conference
2013
Unique Device Identification
The Device Identifier
This code identifies a specific product (model
variant) and acts as a key to access the Unique
Device Identifier Database (UDID)
20. Paul A Blackett: SBK Compliance Conference
2013
Unique Device Identification
+ = UDI
The Production Identifier The Device Identifier
Already stored
on our databases
Something new
to store!
22. Paul A Blackett: SBK Compliance Conference
2013
UDI Database
•Data submitted by Manufacturers
•Single database or possibly a
network of national ones that
update each other.
•Publicly and internationally
accessible - free of charge.
23. Paul A Blackett: SBK Compliance Conference
2013
Device IdentifierDevice Identifier
CodeCode
24. Paul A Blackett: SBK Compliance Conference
2013
Unlocking the UDI
25. Paul A Blackett: SBK Compliance Conference
2013
Unlocking the UDI
• Manufacturers name
• Manufacturers address
• Contact name (if different)
• GMDN code
• Any Trade or Brand name
• Device Model number
• Controlled by…
(serial/batch/lot)
• and…
26. Paul A Blackett: SBK Compliance Conference
2013
Unlocking the UDI
• Sterile or non-sterile
• Contains latex or not
• Size and unit of
measure (if relevant)
• Packing quantity
27. Paul A Blackett: SBK Compliance Conference
2013
Practical Uses of the UDI
• Tracking and tracing
• MHRA alerts
• Adverse Incident reports
• Recalls of implants
• Counterfeit control
• Populating databases with correct data
• Procurement improvements
29. Paul A Blackett: SBK Compliance Conference
2013
Automatic
Identification and
Data Capture
30. Paul A Blackett: SBK Compliance Conference
2013
Formats
• UDI should be readable in human and digital form
• Any digital formats can be used that conform to an
ISO format
31. Paul A Blackett: SBK Compliance Conference
2013
Coding
• DH encouraging common data structures -
Coding for Success in 2007 [7]
– GS1 coding for patient and equipment use
– Register with GS1uk (300+ trusts reg’d)
– Recommended by the NAO [8]
and Lord Hunt [9]
• Considered by Parliament
– DH to progress implementation [10]
32. Paul A Blackett: SBK Compliance Conference
2013
GS1 Coding
• Patient wrist band identification
• Drugs
• Medical Equipment
• Staff
33. Paul A Blackett: SBK Compliance Conference
2013
[F1]8004505521790000023672
GIAI
Global Individual Asset Identifier Site code
Local number
GS1 identifier
Format and coding in practice
34. Paul A Blackett: SBK Compliance Conference
2013
In Summary…
• GMDN – FDA will adopt as part of UDI
–Some UK hospitals already registered
• UDI Mentioned in EU Medical Devices
Regulations revision [11]
• UDI-US adopting this year
• UDI-MHRA acknowledged [12]
• GS1 – Already here.
35. Paul A Blackett: SBK Compliance Conference
2013
Time to get
Prepared!
10
10
36. Paul A Blackett: SBK Compliance Conference
2013
1 Register with the GMDN Agency
Look into changing to GMDN
2 Contact your database support
and ask if they are ready for UDI
3 If your Trust hasn’t already done
so, register with GS1uk and think
about labelling integration
38. Paul A Blackett: SBK Compliance Conference
2013
References and suggestions for further study
[1] http://www.gmdnagency.com/
[2] http://www.gmdnagency.org/Downloads/GMDN_Agency_User_Guide_v120810.pdf
[3] http://www.ihtsdo.org/news/article/article/ihtsdo-and-gmdna-signs-cooperation-agreement/
[4] GHTF 2010 Unique Device Information for Medical Devices
http://www.ghtf.org/documents/ahwg/AHWG-PD2-N2R2.pdf no longer available see instead:
http://www.imdrf.org/docs/imdrf/final/work-items/imdrf-wi-120923-presentation-udi.pdf#search="revised
udi guidance“
[5] http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm310505.htm
[6] http://www.udiconference.com
[7] DH 2007 Coding for Success.
http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_066082
[8] GS1-uk 2010 http://www.gs1uk.org/news/Pages/GS1UKNewsDetails.aspx?NewsID=445
[9] http://www.connectingforhealth.nhs.uk/systemsandservices/aidc/background
[10] http://www.publications.parliament.uk/pa/cm200809/cmselect/cmhealth/151/15110.htm
[11] Revision of Medical Device Directive
http://www.mhra.gov.uk/Publications/Consultations/Deviceconsultations/CON205361
page 20 #15.4
[12] MHRA Draft 2013-2018 corporate plan
http://www.mhra.gov.uk/home/groups/comms-ic/documents/publication/con216948.pdf
see page9 for UDI information
Thank you for your attention Paul.Blackett@lthtr.nhs.uk